| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |